JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1989) 2, 93-98    DOI: 10.1677/jme.0.0020093
© 1989 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Göke, R.
Right arrow Articles by Conlon, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Göke, R.
Right arrow Articles by Conlon, J. M.

Characterization of the receptor for glucagon-like peptide-1(7–36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking

R. Göke, T. Cole and J. M. Conlon

125I-Labelled glucagon-like peptide-1(7–36)amide was cross-linked to a specific binding protein in plasma membranes prepared from RINm5F rat insulinoma-derived cells using disuccinimidyl suberate. Consistent with the presence of a single class of binding site on the surface of intact cells, only a single radiolabelled band at Mr 63 000 was identified by SDS-PAGE after solubilization of the ligand—binding protein complex. The band was not observed when 10 nM glucagon-like peptide-1(7–36)amide was included in the binding assay, but 1 µM concentrations of glucagon-like peptide1(1–36)amide, glucagon-like peptide-2 and glucagon did not decrease the intensity of labelling. No change in the mobility of the band was observed under reducing conditions, suggesting that the binding protein in the receptor is not attached to other subunits via disulphide bonds. In control incubations using plasma membranes from pig intestinal epithelial cells, which do not contain specific binding sites for glucagon-like peptide-1(7–36)amide, no cross-linked ligand-binding protein complex was observed.




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Ebinger, D. R. Jehle, R. D. Fussgaenger, H. C. Fehmann, and P. M. Jehle
Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E88 - E94.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. J. Kieffer and J. Francis Habener
The Glucagon-Like Peptides
Endocr. Rev., December 1, 1999; 20(6): 876 - 913.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
I. Wildhage, H. Trusheim, B. Göke, and B. Lankat-Buttgereit
Gene Expression of the Human Glucagon-Like Peptide-1 Receptor Is Regulated by Sp1 and Sp3
Endocrinology, February 1, 1999; 140(2): 624 - 631.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Heron, A. Virsolvy, K. Peyrollier, F. M. Gribble, A. Le Cam, F. M. Ashcroft, and D. Bataille
Human alpha -endosulfine, a possible regulator of sulfonylurea-sensitive KATP channel: Molecular cloning, expression and biological properties
PNAS, July 7, 1998; 95(14): 8387 - 8391.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Benito, E. Blazquez, and M. A. Bosch
Glucagon-Like Peptide-1-(7-36)Amide Increases Pulmonary Surfactant Secretion through a Cyclic Adenosine 3',5'-Monophosphate-Dependent Protein Kinase Mechanism in Rat Type II Pneumocytes
Endocrinology, May 1, 1998; 139(5): 2363 - 2368.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the Society for Endocrinology.